Shilajit (Mumio) Elicits Apoptosis and Suppresses Cell Migration in Oral Cancer Cells through Targeting Urokinase-type Plasminogen Activator and Its Receptor and Chemokine Signaling Pathways

ABSTRACT

Background: Shilajit a natural phytomineral has a proven record of treating many human body ailments. Objectives: This study aimed to explore the influence of Shilajit on cell proliferation and apoptosis induction in oral cancer cells (OCC) and to comprehend the molecular mechanism associated with OCC migration. Materials and Methods: Human gingival fibroblast (hGF) and OCC (KB-1 (KERATIN-forming tumor cell line HeLa)) were exposed to Shilajit solution dilutions. Cell growth and apoptosis were measured by MTT and Annexin-V tests (control/test group). Cellular morphology using an inverted microscope, cellular apoptosis using acridine orange/ethidium bromide dual staining, reactive oxygen species production analysis using 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) staining, and gene protein expression using real-time polymerase chain reaction test were used to measure study outcomes. The data enumerated were the average of three trial experiments. Categorical and numerical data were expressed as frequency distribution and means, respectively. Differences in groups (control/test; zero/24 h/48 h) were determined using Student’s t-test and one way analysis of variance, with probability ‘p’ value considered significant at ≤0.05. Results: The viability of OCC exhibited a concentration and time-dependent response to Shilajit. Notably, Shilajit demonstrated selectivity against cancer cells. Through an examination of the Annexin-V apoptosis assay, it was observed that Shilajit induces apoptosis by upregulating the proapoptotic gene expression (p ≤ 0.05) and downregulating antiapoptotic proteins (p ≤ 0.05). Furthermore, the impact of Shilajit on cell migration decreased significantly when compared to control cells through modulating the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) and chemokines gene expression. Conclusion: Shilajit exhibited greater cytotoxicity, decreased OCC proliferation and migration, and initiated OCC apoptosis as equivalent to normal cells. These promising outcomes indicate that Shilajit holds potential as a robust, promising option for oral cancer treatment, underscoring the need for further research in this domain.

KEYWORDS

• Oral cancer
• Shilajit
• apoptosis
• uPA/uPAR
• chemokines
• cell migration

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241275740Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 2Pinobanksin Attenuates Cerebral Ischemia– Reperfusion Injury in Rats through Mitigating the Inflammatory ResponsesTianmin Bie, Feng Jia, Yongmei Wang, Zhuoyan Pan · pp. 413–422Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Extraction and in vitro and in vivo Antioxidant Activity Evaluation of Polyphenols from Lychee PericarpYing Wang, Hong Deng, Chuqin Yu, Junfeng Ban, Shu Zhang · pp. 423–432Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Discussion about the Role of Ghrelin in Myocardial Ischemia/Reperfusion and its Possible MechanismGang Huang, Nan Zheng, Yinqing Huang · pp. 433–442Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Sanggenol L Reduces LPS-induced Myocardial Injury and Inflammation by Activating PI3K/ AKT/mTOR and Inhibiting NF-κB in RatsHaojun Wang, Tao Jin, Yuehan Mao, Yi Wei · pp. 443–453Original Research ArticleSame type: Article